{"id":3385,"date":"2020-10-31T10:35:36","date_gmt":"2020-10-31T09:35:36","guid":{"rendered":"https:\/\/www.ab-science.com\/evenements\/"},"modified":"2021-01-20T16:58:46","modified_gmt":"2021-01-20T15:58:46","slug":"evenements","status":"publish","type":"page","link":"https:\/\/www.ab-science.com\/fr\/investisseurs\/evenements\/","title":{"rendered":"\u00c9v\u00e9nements"},"content":{"rendered":"

[vc_row el_class=\u00a0\u00bbevent\u00a0\u00bb][vc_column]

<\/span>R\u00e9sum\u00e9 des congr\u00e8s scientifiques et des conf\u00e9rences<\/span><\/div><\/div>
<\/div>
<\/div>[vc_custom_heading text=\u00a0\u00bbFormes Progressives de la Scl\u00e9rose en plaques\u00a0\u00bb font_container=\u00a0\u00bbtag:h3|text_align:left|color:%23ffffff\u00a0\u00bb google_fonts=\u00a0\u00bbfont_family:Lato%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C700%2C700italic%2C900%2C900italic|font_style:700%20bold%20regular%3A700%3Anormal\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1611158211979{padding-top: 10px !important;padding-right: 10px !important;padding-bottom: 10px !important;padding-left: 10px !important;background-color: #00477a !important;}\u00a0\u00bb]
<\/div>[vc_column_text]<\/p>\n\n\n\n\n\n
Congr\u00e8s \/ Conf\u00e9rence <\/strong><\/td>\nAnn\u00e9e<\/strong><\/td>\nPr\u00e9sent\u00e9 par<\/strong><\/td>\nTitre<\/strong><\/td>\nPr\u00e9sentation<\/strong><\/td>\n<\/tr>\n
Americas and European Committees for Treatment and Research in Multiple Sclerosis (ACTRIMS-ECTRIMS) Annual Congress: MSVirtual2020<\/td>\n2020<\/td>\nProf Patrick Vermersch<\/td>\nMasitinib in Primary Progressive (PPMS) and Non-Active Secondary Progressive (nSPMS) Multiple Sclerosis: Results from Phase 3 Study AB07002<\/td>\nR\u00e9sum\u00e9<\/a><\/td>\n<\/tr>\n
Masitinib in Primary Progressive (PPMS) and Non-Active Secondary Progressive (nSPMS) Multiple Sclerosis: Results from Phase 3 Study AB07002<\/td>\nPr\u00e9sentation<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

[\/vc_column_text]

<\/div>
<\/div>[vc_custom_heading text=\u00a0\u00bbAsthme s\u00e9v\u00e8re\u00a0\u00bb font_container=\u00a0\u00bbtag:h3|text_align:left|color:%23ffffff\u00a0\u00bb google_fonts=\u00a0\u00bbfont_family:Lato%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C700%2C700italic%2C900%2C900italic|font_style:700%20bold%20regular%3A700%3Anormal\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1604565640896{padding-top: 10px !important;padding-right: 10px !important;padding-bottom: 10px !important;padding-left: 10px !important;background-color: #00477a !important;}\u00a0\u00bb]
<\/div>[vc_column_text]<\/p>\n\n\n\n\n\n\n\n\n\n\n\n
Congr\u00e8s \/ Conf\u00e9rence<\/strong><\/td>\n\n

Ann\u00e9e<\/strong><\/p>\n<\/td>\n

Pr\u00e9sent\u00e9 par
\n<\/strong><\/td>\n		Titre<\/strong><\/td>\n\n

Pr\u00e9sentation<\/strong><\/p>\n<\/td>\n<\/tr>\n

American Thoracic Society<\/p>\n

ATS 2020 VIRTUAL<\/td>\n

\n

2020<\/p>\n<\/td>\n

Prof Pascal Chanez<\/td>\nMasitinib Significantly Decreases the Rate of Asthma Exacerbations in Patients with Severe Asthma Uncontrolled by Oral Corticosteroids: A phase 3 Multicenter Study<\/td>\n\n

R\u00e9sum\u00e9<\/a><\/p>\n<\/td>\n<\/tr>\n

\n

Poster<\/a><\/p>\n<\/td>\n<\/tr>\n

\n

Pr\u00e9sentation<\/a><\/p>\n<\/td>\n<\/tr>\n

European Respiratory Society<\/p>\n

ERS2020 ALERT<\/td>\n

\n

2020<\/p>\n<\/td>\n

Prof Pascal Chanez<\/td>\nMasitinib in Severe Asthma: Results from a Randomized, Phase 3 Trial<\/td>\n\n

Pr\u00e9sentation<\/a><\/p>\n<\/td>\n<\/tr>\n

\n

Poster<\/a><\/p>\n<\/td>\n<\/tr>\n

\n

R\u00e9sum\u00e9<\/a><\/p>\n<\/td>\n<\/tr>\n

European Academy of Allergy & Clinical Immunology (EAACI) 2020 Congress<\/td>\n\n

2020<\/p>\n<\/td>\n

Prof Lavinia Davidescu<\/td>\nEfficacy and Safety of Masitinib in Severe Asthma: Results From Study AB07015<\/td>\n\n

Pr\u00e9sentation<\/a><\/p>\n<\/td>\n<\/tr>\n

Efficacy and Safety of Masitinib in Severe Asthma: Eosinophilic Subgroup Analysis from Study AB07015<\/td>\n\n

R\u00e9sum\u00e9<\/a><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

[\/vc_column_text]

<\/div>
<\/div>[vc_custom_heading text=\u00a0\u00bbScl\u00e9rose lat\u00e9rale amyotrophique\u00a0\u00bb font_container=\u00a0\u00bbtag:h3|text_align:left|color:%23ffffff\u00a0\u00bb google_fonts=\u00a0\u00bbfont_family:Lato%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C700%2C700italic%2C900%2C900italic|font_style:700%20bold%20regular%3A700%3Anormal\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1604565656232{padding-top: 10px !important;padding-right: 10px !important;padding-bottom: 10px !important;padding-left: 10px !important;background-color: #00477a !important;}\u00a0\u00bb]
<\/div>[vc_column_text]<\/p>\n\n\n\n\n\n\n
Congr\u00e8s \/ Conf\u00e9rence<\/strong><\/td>\nAnn\u00e9e<\/strong><\/td>\nPr\u00e9sent\u00e9 par<\/strong><\/td>\nTitre<\/strong><\/td>\nPr\u00e9sentation<\/strong><\/td>\n<\/tr>\n
ENCALS Annual Meeting<\/td>\n2018<\/td>\nDr Jesus S Mora<\/td>\nInitiation of Masitinib at a Less Severe Stage of Disease Produces Greater Treatment-Effect: Subgroup Analyses from Masitinib Study AB10015<\/td>\nR\u00e9sum\u00e9 \/ Poster<\/a><\/td>\n<\/tr>\n
2018<\/td>\nProf Olivier Hermine<\/td>\nSensitivity Analyses from the First Phase 3 Clinical Study of Masitinib (AB10015) in ALS Demonstrate Robustness of the Positive Primary Analysis<\/td>\nR\u00e9sum\u00e9 \/ Poster<\/a><\/td>\n<\/tr>\n
2018<\/td>\nProf Luis Barbeito<\/td>\nMasitinib therapeutically targets sciatic nerve pathology associated with paralysis progression in an inherited ALS model<\/td>\nR\u00e9sum\u00e9<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

[\/vc_column_text]

<\/div>
<\/div>[vc_custom_heading text=\u00a0\u00bbMaladie d’Alzheimer\u00a0\u00bb font_container=\u00a0\u00bbtag:h3|text_align:left|color:%23ffffff\u00a0\u00bb google_fonts=\u00a0\u00bbfont_family:Lato%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C700%2C700italic%2C900%2C900italic|font_style:700%20bold%20regular%3A700%3Anormal\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1604565678535{padding-top: 10px !important;padding-right: 10px !important;padding-bottom: 10px !important;padding-left: 10px !important;background-color: #00477a !important;}\u00a0\u00bb]
<\/div>[vc_column_text]<\/p>\n\n\n\n\n\n
Congr\u00e8s \/ Conf\u00e9rence<\/strong><\/td>\n\n

Ann\u00e9e<\/strong><\/p>\n<\/td>\n

Pr\u00e9sent\u00e9 par<\/strong><\/td>\nTitre<\/strong><\/td>\n\n

Pr\u00e9sentation<\/strong><\/p>\n<\/td>\n<\/tr>\n

14th International Athens\/Springfield Symposium on Advances in Alzheimer Therapy<\/td>\n\n

2016<\/p>\n<\/td>\n

Prof Olivier Hermine<\/td>\nMasitinib for the Treatment of Alzheimer\u2019s Disease: Clinical and Preclinical Data<\/td>\n\n

Pr\u00e9sentation \/ R\u00e9sum\u00e9<\/a><\/p>\n<\/td>\n<\/tr>\n

Masitinib for the Treatment of Alzheimer\u2019s Disease: a Randomized Phase 3 Trial<\/td>\n\n

Poster<\/a><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

[\/vc_column_text]

<\/div>
<\/div>[vc_custom_heading text=\u00a0\u00bbAB8939″ font_container=\u00a0\u00bbtag:h3|text_align:left|color:%23ffffff\u00a0\u00bb google_fonts=\u00a0\u00bbfont_family:Lato%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C700%2C700italic%2C900%2C900italic|font_style:700%20bold%20regular%3A700%3Anormal\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1604565697697{padding-top: 10px !important;padding-right: 10px !important;padding-bottom: 10px !important;padding-left: 10px !important;background-color: #00477a !important;}\u00a0\u00bb]
<\/div>[vc_column_text]<\/p>\n\n\n\n\n\n\n\n
Congr\u00e8s \/ Conf\u00e9rence<\/strong><\/td>\nAnn\u00e9e<\/strong><\/td>\nPr\u00e9sent\u00e9 par<\/strong><\/td>\nTitre<\/strong><\/td>\nPr\u00e9sentation<\/strong><\/td>\n<\/tr>\n
European Hematology Association (EHA) Annual Congress<\/td>\n2020<\/td>\nProf Olivier Hermine<\/td>\nAB8939, a Novel Microtubule-Destabilizing Agent for the Treatment of Acute Myeloid Leukemia<\/td>\nPoster<\/a><\/td>\n<\/tr>\n
American Society of Hematology (ASH) Annual Meeting<\/td>\n2019<\/td>\nProf Olivier Hermine<\/td>\nAnticancer Activity of a Highly Potent Small Molecule Tubulin Polymerization Inhibitor, AB8939<\/td>\nR\u00e9sum\u00e9 \/ Poster<\/a><\/td>\n<\/tr>\n
AB8939, a Microtubule-Destabilizing Agent with Potential to Overcome Multidrug Resistance, is Active Across the Range (M0\u2013M7) of Acute Myeloid Leukemia Subtypes<\/td>\nR\u00e9sum\u00e9<\/a><\/td>\n<\/tr>\n
In Vivo Assessment of the Next Generation Microtubule-Destabilizing Agent AB8939 in Patient-derived Xenograft Models of Acute Myeloid Leukemia<\/td>\nR\u00e9sum\u00e9<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row el_class=\u00a0\u00bbevent\u00a0\u00bb][vc_column][vc_custom_heading text=\u00a0\u00bbFormes Progressives de la Scl\u00e9rose en plaques\u00a0\u00bb font_container=\u00a0\u00bbtag:h3|text_align:left|color:%23ffffff\u00a0\u00bb google_fonts=\u00a0\u00bbfont_family:Lato%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C700%2C700italic%2C900%2C900italic|font_style:700%20bold%20regular%3A700%3Anormal\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1611158211979{padding-top: 10px !important;padding-right: 10px !important;padding-bottom: 10px !important;padding-left: 10px !important;background-color: #00477a !important;}\u00a0\u00bb][vc_column_text] Congr\u00e8s \/ Conf\u00e9rence Ann\u00e9e Pr\u00e9sent\u00e9 par Titre Pr\u00e9sentation Americas and European Committees for Treatment and Research in Multiple Sclerosis (ACTRIMS-ECTRIMS) Annual Congress: MSVirtual2020 2020 Prof Patrick Vermersch Masitinib in Primary Progressive (PPMS) and…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":3588,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3385","page","type-page","status-publish","hentry","description-off"],"yoast_head":"\n\u00c9v\u00e9nements – AB Science<\/title>\n<meta name=\"description\" content=\"Publications des congr\u00e8s scientifiques et des conf\u00e9rences, r\u00e9sum\u00e9s, pr\u00e9sentations, affiches, toutes les publications lors des \u00e9v\u00e9nements\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ab-science.com\/fr\/investisseurs\/evenements\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00c9v\u00e9nements\" \/>\n<meta property=\"og:description\" content=\"Publications des congr\u00e8s scientifiques et des conf\u00e9rences, r\u00e9sum\u00e9s, pr\u00e9sentations, affiches, toutes les publications lors des \u00e9v\u00e9nements\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ab-science.com\/fr\/investisseurs\/evenements\/\" \/>\n<meta property=\"og:site_name\" content=\"AB Science\" \/>\n<meta property=\"article:modified_time\" content=\"2021-01-20T15:58:46+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/investisseurs\\\/evenements\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/investisseurs\\\/evenements\\\/\",\"name\":\"\u00c9v\u00e9nements – AB Science\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#website\"},\"datePublished\":\"2020-10-31T09:35:36+00:00\",\"dateModified\":\"2021-01-20T15:58:46+00:00\",\"description\":\"Publications des congr\u00e8s scientifiques et des conf\u00e9rences, r\u00e9sum\u00e9s, pr\u00e9sentations, affiches, toutes les publications lors des \u00e9v\u00e9nements\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/investisseurs\\\/evenements\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/investisseurs\\\/evenements\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/investisseurs\\\/evenements\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investisseurs\",\"item\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/investisseurs\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"\u00c9v\u00e9nements\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"name\":\"AB Science\",\"description\":\"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\",\"name\":\"AB Science\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"contentUrl\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"width\":120,\"height\":120,\"caption\":\"AB Science\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ab-science\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u00c9v\u00e9nements – AB Science","description":"Publications des congr\u00e8s scientifiques et des conf\u00e9rences, r\u00e9sum\u00e9s, pr\u00e9sentations, affiches, toutes les publications lors des \u00e9v\u00e9nements","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ab-science.com\/fr\/investisseurs\/evenements\/","og_locale":"fr_FR","og_type":"article","og_title":"\u00c9v\u00e9nements","og_description":"Publications des congr\u00e8s scientifiques et des conf\u00e9rences, r\u00e9sum\u00e9s, pr\u00e9sentations, affiches, toutes les publications lors des \u00e9v\u00e9nements","og_url":"https:\/\/www.ab-science.com\/fr\/investisseurs\/evenements\/","og_site_name":"AB Science","article_modified_time":"2021-01-20T15:58:46+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ab-science.com\/fr\/investisseurs\/evenements\/","url":"https:\/\/www.ab-science.com\/fr\/investisseurs\/evenements\/","name":"\u00c9v\u00e9nements – AB Science","isPartOf":{"@id":"https:\/\/www.ab-science.com\/fr\/#website"},"datePublished":"2020-10-31T09:35:36+00:00","dateModified":"2021-01-20T15:58:46+00:00","description":"Publications des congr\u00e8s scientifiques et des conf\u00e9rences, r\u00e9sum\u00e9s, pr\u00e9sentations, affiches, toutes les publications lors des \u00e9v\u00e9nements","breadcrumb":{"@id":"https:\/\/www.ab-science.com\/fr\/investisseurs\/evenements\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ab-science.com\/fr\/investisseurs\/evenements\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ab-science.com\/fr\/investisseurs\/evenements\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.ab-science.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Investisseurs","item":"https:\/\/www.ab-science.com\/fr\/investisseurs\/"},{"@type":"ListItem","position":3,"name":"\u00c9v\u00e9nements"}]},{"@type":"WebSite","@id":"https:\/\/www.ab-science.com\/fr\/#website","url":"https:\/\/www.ab-science.com\/fr\/","name":"AB Science","description":"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action","publisher":{"@id":"https:\/\/www.ab-science.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ab-science.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ab-science.com\/fr\/#organization","name":"AB Science","url":"https:\/\/www.ab-science.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","contentUrl":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","width":120,"height":120,"caption":"AB Science"},"image":{"@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/ab-science\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/pages\/3385","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/comments?post=3385"}],"version-history":[{"count":0,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/pages\/3385\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/pages\/3588"}],"wp:attachment":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/media?parent=3385"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}